Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Scott Gottlieb
Scott Gottlieb
Biotech Executives Fret Over Hassles And Uncertainties Of 'Right To Try'
Forbes
Wed, 06/13/18 - 10:02 am
FDA
Scott Gottlieb
biotech
right-to-try laws
'Patient-focused' drug development guidance coming, FDA chief says
Biopharma Dive
Tue, 06/12/18 - 11:17 am
FDA
patients
drug development
Scott Gottlieb
Gottlieb at BIO: FDA developing processes around right-to-try law
Med City News
Fri, 06/8/18 - 11:44 pm
FDA
Scott Gottlieb
right-to-try laws
FDA wants to shorten new drug monopolies to cut costs
Reuters
Mon, 06/4/18 - 11:33 am
competition
drug pricing
FDA
Scott Gottlieb
drug approvals
Mitigating Drug Shortages: FDA Moves to Address Challenges
RAPS.org
Thu, 05/31/18 - 07:54 pm
FDA
drug shortages
Scott Gottlieb
FDA plans to speed path to approval for some gene therapies, starting with hemophilia
Stat
Tue, 05/22/18 - 06:38 pm
FDA
drug approvals
gene therapies
Scott Gottlieb
hemophilia
FDA executes an abrupt about-face as sole-source contract for ex-agency chief Mark McClellan draws the spotlight
Endpoints
Sat, 05/19/18 - 11:21 am
FDA
Scott Gottlieb
FDA looking at ways to include price info in drug ads, Gottlieb says, as questions loom
Stat
Fri, 05/18/18 - 09:50 am
FDA
Scott Gottlieb
drug pricing
drug ads
Right-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says
Stat
Thu, 05/17/18 - 09:37 pm
FDA
right-to-try laws
Scott Gottlieb
Gottlieb pushes back against criticism of ‘breakthrough’ designation
Stat
Mon, 05/7/18 - 09:55 am
FDA
breakthrough status
Scott Gottlieb
FDA chief suggests kickback laws could be used to rein in drug prices
Drug Delivery Business News
Fri, 05/4/18 - 10:03 am
FDA
Scott Gottlieb
PBMs
drug rebates
Interview With Gottlieb: A Discussion on Biosimilars, Opioids and Transparency
RAPS.org
Sat, 04/21/18 - 12:29 am
FDA
Scott Gottlieb
biosimilars
generics
opioids
transparency
FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma
Endpoints
Wed, 04/18/18 - 09:31 am
FDA
Scott Gottlieb
drug development
In bid to lower prices, Gottlieb says FDA will take new action to speed approval of biosimilars
Stat
Wed, 03/28/18 - 07:12 pm
FDA
Scott Gottlieb
biosimilars
drug approvals
After a rough season, FDA chief Gottlieb says 'holy grail' flu shot is years off
Fierce Pharma
Wed, 03/14/18 - 10:11 am
vaccines
FDA
flu vaccines
Scott Gottlieb
universal flu vaccine
FDA'S Bigger Piggy Bank
BioCentury
Tue, 02/20/18 - 10:43 pm
FDA
Scott Gottlieb
FDA’s Gottlieb outlines new goals in budget plan, looking to spur drug reviews
Endpoints
Thu, 02/15/18 - 10:58 am
FDA
Scott Gottlieb
drug reviews
Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years
Endpoints
Fri, 12/15/17 - 09:33 am
Amicus
Pharma CEOs
FDA
Scott Gottlieb
migalastat
Fabry disease
FDA Boss Aims To Close EpiPen Loophole
Forbes
Tue, 11/28/17 - 11:10 am
FDA
Scott Gottlieb
EpiPens
generics
Mylan Labs
FDA eyes even more pricing competition with another round of generics moves
Fierce Pharma
Tue, 11/14/17 - 11:51 am
FDA
drug pricing
generics
competition
Scott Gottlieb
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »